The contraindications to alosetron include

- Chronic or severe constipation or any sequelae from constipation

- Intestinal obstruction or stricture, toxic megacolon, gastrointestinal perforation, and/or adhesions

- Diverticulitis

- Crohn disease or ulcerative colitis

- Ischemic colitis, thrombophlebitis, impaired intestinal circulation, or hypercoagulable state

- Severe hepatic impairment

- History of blood clots

- Concomitant use of fluvoxamine as fluvoxamine is a strong inhibitor of CYP1A2. Research has shown it to increase the mean plasma concentration of alosetron by approximately 6-fold and prolong the half-life by 3-fold.